Concepts (91)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Seizures | 3 | 2018 | 67 | 1.090 |
Why?
|
| Status Epilepticus | 2 | 2018 | 21 | 1.080 |
Why?
|
| Critical Care | 2 | 2017 | 113 | 0.960 |
Why?
|
| Posterior Leukoencephalopathy Syndrome | 2 | 2015 | 4 | 0.910 |
Why?
|
| Stroke | 5 | 2019 | 700 | 0.900 |
Why?
|
| Cranial Fossa, Posterior | 2 | 2015 | 4 | 0.860 |
Why?
|
| Vasospasm, Intracranial | 2 | 2021 | 13 | 0.680 |
Why?
|
| Anticonvulsants | 2 | 2018 | 62 | 0.670 |
Why?
|
| Brain Ischemia | 2 | 2018 | 160 | 0.610 |
Why?
|
| Brain Infarction | 2 | 2018 | 10 | 0.580 |
Why?
|
| Cerebrovascular Circulation | 2 | 2019 | 104 | 0.580 |
Why?
|
| Intracranial Hemorrhages | 2 | 2014 | 35 | 0.540 |
Why?
|
| Nervous System Diseases | 2 | 2017 | 47 | 0.530 |
Why?
|
| Phenylephrine | 1 | 2017 | 35 | 0.520 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2017 | 25 | 0.510 |
Why?
|
| Vasoconstrictor Agents | 1 | 2017 | 65 | 0.510 |
Why?
|
| Registries | 1 | 2018 | 328 | 0.490 |
Why?
|
| Cerebrospinal Fluid Proteins | 1 | 2015 | 4 | 0.470 |
Why?
|
| Leukocytosis | 1 | 2015 | 8 | 0.470 |
Why?
|
| Cerebrospinal Fluid | 1 | 2015 | 18 | 0.460 |
Why?
|
| Brain | 3 | 2021 | 1031 | 0.460 |
Why?
|
| Vertebrobasilar Insufficiency | 1 | 2015 | 7 | 0.450 |
Why?
|
| Collateral Circulation | 1 | 2015 | 10 | 0.450 |
Why?
|
| Apnea | 1 | 2014 | 6 | 0.440 |
Why?
|
| Brain Death | 1 | 2014 | 27 | 0.440 |
Why?
|
| Cerebellar Diseases | 1 | 2014 | 4 | 0.440 |
Why?
|
| Carotid Stenosis | 1 | 2015 | 61 | 0.440 |
Why?
|
| Cerebellum | 1 | 2014 | 27 | 0.430 |
Why?
|
| Liver Failure, Acute | 1 | 2014 | 10 | 0.410 |
Why?
|
| Odontoid Process | 1 | 2013 | 2 | 0.410 |
Why?
|
| Epilepsy | 1 | 2015 | 86 | 0.410 |
Why?
|
| Hematoma | 1 | 2013 | 27 | 0.400 |
Why?
|
| Spinal Fractures | 1 | 2013 | 44 | 0.390 |
Why?
|
| Humans | 16 | 2021 | 34475 | 0.360 |
Why?
|
| Retrospective Studies | 5 | 2018 | 3812 | 0.340 |
Why?
|
| Male | 7 | 2018 | 20697 | 0.240 |
Why?
|
| Aged | 5 | 2018 | 10999 | 0.240 |
Why?
|
| Hypotension | 2 | 2017 | 49 | 0.230 |
Why?
|
| Middle Aged | 6 | 2021 | 12703 | 0.200 |
Why?
|
| Female | 7 | 2021 | 21491 | 0.190 |
Why?
|
| Antacids | 1 | 2021 | 4 | 0.170 |
Why?
|
| Calcium Carbonate | 1 | 2021 | 8 | 0.170 |
Why?
|
| Hypercalcemia | 1 | 2021 | 13 | 0.170 |
Why?
|
| Vascular Resistance | 1 | 2019 | 33 | 0.160 |
Why?
|
| Aged, 80 and over | 2 | 2018 | 4151 | 0.160 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 1 | 2019 | 34 | 0.150 |
Why?
|
| Time Factors | 2 | 2015 | 2352 | 0.150 |
Why?
|
| Cerebral Angiography | 2 | 2021 | 60 | 0.150 |
Why?
|
| Treatment Outcome | 2 | 2018 | 3618 | 0.140 |
Why?
|
| Hypertension | 2 | 2015 | 1024 | 0.140 |
Why?
|
| Electroencephalography | 1 | 2018 | 76 | 0.140 |
Why?
|
| Adult | 3 | 2015 | 10015 | 0.130 |
Why?
|
| Infusions, Intravenous | 1 | 2017 | 110 | 0.130 |
Why?
|
| Catheterization, Peripheral | 1 | 2017 | 29 | 0.130 |
Why?
|
| Disease Management | 1 | 2018 | 134 | 0.130 |
Why?
|
| Intensive Care Units | 1 | 2017 | 123 | 0.120 |
Why?
|
| Hemodynamics | 1 | 2017 | 168 | 0.120 |
Why?
|
| Cerebrospinal Fluid Pressure | 1 | 2015 | 2 | 0.120 |
Why?
|
| Minnesota | 1 | 2015 | 20 | 0.120 |
Why?
|
| Spinal Puncture | 1 | 2015 | 22 | 0.120 |
Why?
|
| Leukocyte Count | 1 | 2015 | 49 | 0.120 |
Why?
|
| Unconsciousness | 1 | 2015 | 5 | 0.110 |
Why?
|
| Vomiting | 1 | 2015 | 23 | 0.110 |
Why?
|
| Immunosuppression | 1 | 2015 | 120 | 0.110 |
Why?
|
| Hypoxia, Brain | 1 | 2014 | 4 | 0.110 |
Why?
|
| Diagnostic Techniques, Neurological | 1 | 2014 | 8 | 0.110 |
Why?
|
| Blood Gas Analysis | 1 | 2014 | 19 | 0.110 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2017 | 565 | 0.110 |
Why?
|
| Sella Turcica | 1 | 2014 | 1 | 0.110 |
Why?
|
| Sphenoid Sinus | 1 | 2014 | 3 | 0.110 |
Why?
|
| Hematoma, Subdural, Acute | 1 | 2014 | 6 | 0.110 |
Why?
|
| Brain Injuries | 1 | 2014 | 94 | 0.100 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2021 | 1386 | 0.100 |
Why?
|
| Aneurysm, Ruptured | 1 | 2014 | 33 | 0.100 |
Why?
|
| Stents | 1 | 2015 | 167 | 0.100 |
Why?
|
| Diagnosis, Differential | 1 | 2015 | 540 | 0.100 |
Why?
|
| Fatal Outcome | 1 | 2013 | 87 | 0.100 |
Why?
|
| Reproducibility of Results | 1 | 2015 | 819 | 0.100 |
Why?
|
| Disease Progression | 1 | 2015 | 633 | 0.100 |
Why?
|
| Radiography | 1 | 2013 | 397 | 0.090 |
Why?
|
| Postoperative Complications | 1 | 2017 | 849 | 0.090 |
Why?
|
| Cohort Studies | 1 | 2014 | 1910 | 0.080 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 2366 | 0.080 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2014 | 984 | 0.070 |
Why?
|
| Risk Factors | 1 | 2015 | 4136 | 0.060 |
Why?
|
| Animals | 1 | 2018 | 8544 | 0.060 |
Why?
|
| Nimodipine | 1 | 2021 | 2 | 0.040 |
Why?
|
| Calcium Channel Blockers | 1 | 2021 | 54 | 0.040 |
Why?
|
| Diffusion Magnetic Resonance Imaging | 1 | 2021 | 56 | 0.040 |
Why?
|
| Blood Flow Velocity | 1 | 2019 | 87 | 0.040 |
Why?
|
| Renal Insufficiency, Chronic | 1 | 2019 | 302 | 0.030 |
Why?
|